Category: News
-

Rondo’s 100 MWh Thermal Battery Cuts Industrial Heat Costs by 40%
Learn how Rondo’s 100 MWh thermal battery in California delivers low-cost, low-carbon industrial heat at >97% efficiency, cutting energy bills by 40%.
-

Scrap-to-Hydrogen and Heat Batteries: Two real-world pilots that can cut your industrial fuel
Two large-scale pilots show decarbonized industrial heat is arriving: aluminum–water reactors turn scrap into heat and hydrogen; thermal batteries store…
-

Data engineers become AI kingmakers: MIT Tech Review survey signals urgent shifts in budgets, org
Survey of 400 execs: 72% say data engineers are integral to AI; AI work share jumped 19%→37%, heading to 61%. Turn the shift into ROI with clear moves.
-

How AI CHLOE Boosts IVF ROI and Clinic Capacity
Leverage CHLOE’s FDA-cleared AI to streamline embryo selection, cut genetic biopsies by up to 40%, and accelerate IVF cycles—boosting clinic margins and…
-

Leveraging 25 Years of ISS R&D for Commercial Advantage
Unlock proven space tech—autonomy, laser communications, space-bio—to de-risk next-gen ventures. Secure LEO lab time and pilot ISS-derived solutions now.
-

Maximize Reforestation ROI with Biodiversity Metrics
Leverage MIT’s new seed-dispersal index to de-risk nature credits, boost carbon yields up to 4x, and align with TNFD, VERRA, and Gold Standard.
-

Accelerating Medtech ROI: L4TE’s Full-Stack Venture Studio
L4TE’s MIT/Brigham integrated studio merges fabrication, bioanalytics, and in vivo teams to cut time-to-EFS by 30% and accelerate first-in-human by 6…
-

Bionic Knee ROI: Transforming Mobility & Reducing Costs
Discover how MIT’s neurally integrated bionic knee delivers 25% fewer falls, 0.20 m/s gait gains, and a 3.5-year payback to reshape prosthetics economics.
-

Carbon Nanomaterials: Fueling Next-Gen Profit Growth
Achieve 20% faster charging and 15% weight reduction with graphene/CNT solutions. Learn 90-day pilots, KPIs, EHS, and governance for seamless scale.
-

MIT’s generative AI designs 36M molecules; new antibiotics hit MRSA fast—cutting R&D time, cost,
MIT used generative AI to design 36M molecules and find novel antibiotics against MRSA and drug‑resistant gonorrhea. Expect faster, cheaper R&D and…